VCYT Veracyte Inc.

$5.76 +1.05%

76,543 Shares Traded
120,916 Average Volume (last 30 days)

as of February 23, 2018 EST IEX Real-Time Price

Short Pain Metrics

Approximate Amount of Money Shorts Have Lost on the Day: $44.25 thousand
If Intiated on the First, Shorts Have Realized a Year to Date Return of:15.33%
If Intiated One Month Ago, Shorts Have Realized a Return of:12.46%
If Initiated Five Days ago, Shorts Have Realized a Return of:-1.43%
Peer Potential Short Squeezes Near Real Time Screener
*Please note the actual returns of shorts could be different as they started from different points

Daily Indicators

Daily Short Pain Indicator [i] - Always Use Fundamentals on EverythingNeutral
200 Day Moving Average Indicator Bearish
50 Day Moving Average Indicator Bearish
52 Week High/Low Indicator Neutral

Short Stats

Short Percent to Float 2.17%
Short Interest737.54 thousand
Float33.98 million
Short Ratio6.66
Market Cap$193.69 million
Market Maker ActivityDaily Short Volume


Veracyte to Host Conference Call and Webcast to Discuss Fourth Quarter and Full-Year 2017 Financial Results on Tuesday, February 27, 2018 (Business Wire)
Veracyte to Present at LEERINK Partners 7th Annual Global Healthcare Conference (Business Wire)
Veracyte Announces 100,000th Afirma Test Performed to Reduce Unnecessary Surgeries in Thyroid Cancer Diagnosis (Business Wire)
Veracyte's Chief Science and Medical Officer to Present at The Precision Medicine World Conference (Business Wire)
Veracyte Announces Publication of Results from Patient Survey Quantifying the Challenges in Diagnosing Interstitial Lung Disease (Business Wire)
Veracyte Announces Strategic Realignment and New Appointments to Advance Commercial Growth (Business Wire)
Veracyte Announces Publication of Data Confirming Analytical Validity of Envisia Genomic Classifier for Use in IPF Diagnosis (Business Wire)
Biotech Forum Daily Digest: What Now For Sarepta? (SeekingAlpha)
Veracyte to Present at the Piper Jaffray 29th Annual Healthcare Conference (Business Wire)
Veracyte Announces New Clinical Utility Data Suggesting Envisia Genomic Classifier Enables as Confident a Diagnosis in IPF as Surgical Pathology (Business Wire)

Smart Money Sentiment

Institutional Ownership (Top 15 Funds) 76.3%

Earnings Stats

PE Ratio -7.02
Dividend Yield 0%
Peer EarningsEarnings Calendar


200 Day Moving Average $7.57
50 Day Moving Average $6.35
52 Week High $9.8
52 Week Low $5.23

Data provided for free by IEX. Questions? Read the FAQ